Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

44.36
-0.4600-1.03%
Post-market: 44.360.00000.00%18:42 EDT
Volume:2.35M
Turnover:104.31M
Market Cap:106.29B
PE:23.79
High:44.69
Open:44.59
Low:44.26
Close:44.82
52wk High:52.68
52wk Low:40.89
Shares:2.40B
Float Shares:2.16B
Volume Ratio:1.42
T/O Rate:0.11%
Dividend:2.39
Dividend Rate:5.39%
EPS(TTM):1.86
EPS(LYR):3.76
ROE:5.71%
ROA:5.09%
PB:1.32
PE(LYR):11.80

Loading ...

Sanofi's Dupixent Success Masks R&D Concerns as New CEO Takes the Helm

Stock News
·
Apr 23

Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision

Benzinga_recent_news
·
Apr 22

Sanofi Says Tzield Gets US Approval to Delay Stage 3 Type 1 Diabetes Onset in Young Children

MT Newswires Live
·
Apr 22

Sanofi SA expected to post earnings of $1.03 a share - Earnings Preview

Reuters
·
Apr 21

Sanofi Says Its COVID-19 Vaccine Shows Better Tolerability Than Moderna Alternative in Phase 4 Trial

MT Newswires Live
·
Apr 20

Sanofi says COVID-19 vaccine showed better tolerability than Moderna’s

TIPRANKS
·
Apr 18

France's 2026 Market Story Could Stay Centered On Luxury, Pharma And Banks

Benzinga_recent_news
·
Apr 18

AI Drug Discovery Firm Valued at $1 Billion Following Funding Round, Attracts Investment from Pharma Giants

Deep News
·
Apr 16

Earning Preview: Sanofi SA revenue this quarter is expected to increase by 10.21%, and institutional views are bullish

Earnings Agent
·
Apr 16

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

Regeneron, Sanofi announce European Commission approval for Dupixent indication

TIPRANKS
·
Apr 13

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

GlobeNewswire
·
Apr 13

Sanofi Investors Might Have to Wait for Update on Strategy -- Market Talk

Dow Jones
·
Apr 10

Sanofi Could Get Boost From Dupixent U.S. Price -- Market Talk

Dow Jones
·
Apr 10

Sanofi becomes market authorization holder for Nuvaxovid in Canada

TIPRANKS
·
Apr 09

Sanofi Says Lunsekimig Meets Primary, Key Secondary Endpoints in Phase 2 Respiratory Studies

MT Newswires Live
·
Apr 07

Trump Will Impose 100% Tariff on Some Patented Drugs

Tiger Newspress
·
Apr 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Mar 31

Sanofi Shares Fall After Company Reports Second Cancer Case in Trial -- Market Talk

Dow Jones
·
Mar 30

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Mar 27